Luteolin induces apoptosis, G0/G1 cell cycle growth arrest and mitochondrial membrane potential loss in neuroblastoma brain tumor cells

Drug Research

Volumn 65, Issue 2, 2014, Pages 91-95

  Wang, F ^a   Gao, F ^b   Pan, S ^b   Zhao, S ^a   Xue, Y ^c  

^a WEIFANG MEDICAL UNIVERSITY   (China)

^b People s Hospital of Anqiu   (China)

^c Department of Neurology City Government Organ Hospital of Weifang   (China)

Author keywords

anticancer activity; apoptosis; cell cycle; Luteolin

Indexed keywords

LACTATE DEHYDROGENASE; LUTEOLIN;

ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CELL CYCLE PROGRESSION; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENCY; ENZYME RELEASE; FLOW CYTOMETRY; G1 PHASE CELL CYCLE CHECKPOINT; HUMAN; HUMAN CELL; IC50; MEMBRANE DEPOLARIZATION; MITOCHONDRIAL MEMBRANE POTENTIAL; MTT ASSAY; NEUROBLASTOMA CELL LINE; PHASE CONTRAST MICROSCOPY; BRAIN NEOPLASMS; CELL CYCLE CHECKPOINT; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL DEATH; CELL SURVIVAL; DOSE RESPONSE; DRUG EFFECTS; DRUG SCREENING; NEUROBLASTOMA; PATHOLOGY; TUMOR CELL LINE;

APOPTOSIS; BRAIN NEOPLASMS; CELL CYCLE CHECKPOINTS; CELL DEATH; CELL LINE, TUMOR; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SCREENING ASSAYS, ANTITUMOR; G0 PHASE; G1 PHASE; HUMANS; LUTEOLIN; MEMBRANE POTENTIAL, MITOCHONDRIAL; NEUROBLASTOMA;

EID: 84923545669     PISSN: 21949379     EISSN: 21949387     Source Type: Journal    
DOI: 10.1055/s-0034-1372648     Document Type: Article

References (28)

1. Johnson J. D., Young B. Demographics of brain metastasis. Neurosurgery Clinics of North America: 1996; 7 337 344
2. Posner J. B. Management of brain metastases. Revue Neurologique: 1992; 148 477 487
3. Kim M., Bernstein M. Current treatment of cerebral metastasis. Current Opinion in Neurology: 1996; 9 414 418
4. Wyllie A. H. Apoptosis: An overview. British Medical Bulletin: 1997; 53 451 465
5. Hengartner M. O. The biochemistry of apoptosis. Nature: 2000; 407 770 776
6. Green D. R., Reed J. C. Mitochondria and apoptosis. Science: 1998; 281 1309 1312
7. Fotedar R., Diederich L., Fotedar A. Apoptosis and the cell cycle. Progress in Cell Cycle Research: 1996; 2 147 163
8. Johnson L. V., Walsh M. L., Chen L. B. Localization of mitochondria in living cells with rhodamine 123. Proceedings of the National Academy of Sciences of United States of America: 1980; 77 990 994
9. Kayoko S., Hisae O., Michiyo F. et al. FEBS Letters 438 220 224
10. López-Lázaro M. Distribution and Biological Activities of the Flavonoid Luteolin. Mini-Reviews in Medicinal Chemistry: 2009; 9 31 59
11. Fotsis T., Pepper M. S., Aktas E. et al. Flavonoids, dietary-derived inhibitors of cell proliferation and in vitro angiogenesis. Cancer Research: 1997; 57 2916 2921
12. Kawaii S., Tomono Y., Katase E. et al. Antiproliferative activity of flavonoids on several cancer cell lines. Bioscience Biotechnology and Biochemistry: 1999; 63 896 899
13. Post J. F., Varma R. S. Growth inhibitory effects of bioflavonoids and related compounds on human leukemic CEM-C1 and CEM-Cz cells. Cancer Letters: 1992; 67 207 213
14. Hirobe C., Qiao Z. S., Takeya K. et al. Cytotoxic flavonoids from Vitex agnus-castus. Phytochemistry: 1997; 46 521 524
15. Wang T., Zhang J. C., Chen Y. et al. Comparison of antioxidative and antitumor activities of six flavonoids from Epimedium koreanum. Zhongguo Zhong Yao Za Zhi: 2007; 32 715 718
16. Pettit G. R., Hoard M. S., Doubek D. L. The cancer cell growth inhibitory. Constituents of Terminalia arjuna (Combretaceae). Journal of Ethnopharmacology: 1996; 53 57 63
17. Leung H. W., Kuo C. L., Yang W. H. et al. Antioxidant enzymes activity involvement in luteolin-induced human lung squamous carcinoma CH27 cell apoptosis. European Journal of Pharmacology: 2006; 534 12 18
18. Sharma V., Mishra M., Ghosh S. et al. Modulation of interleukin-1beta mediated inflammatory response in human astrocytes by flavonoids: implications in neuroprotection. Brain Research Bulletin: 2007; 73 55 63
19. Chang H., Mi M. T., Gu Y. Y. et al. Effects of flavonoids with different structures on proliferation of leukemia cell line HL-60 [Article in Chinese]. Ai Zheng: 2007; 26 1309 1314
20. Knowles L. M., Zigrossi D. A., Tauber R. A. et al. Flavonoids suppress androgen-independent human prostate tumor proliferation. Nutrition and Cancer: 2000; 38 116 122
21. Lim do Y., Jeong Y., Tyner A. L. et al. P. Induction of cell cycle arrest and apoptosis in HT-29 human colon cancer cells by the dietary compound luteolin. American Journal of Physiology. Gastrointestinal and Liver Physiology: 2007; 292 G66 G75
22. Leung H. W., Wu C. H., Lin C. H. et al. Luteolin induced DNA damage leading to human lung squamous carcinoma CH27 cell apoptosis. European Journal of Pharmacology: 2005; 508 77 83
23. Kim J. H., Lee E. O., Lee H. J. et al. Caspase activation and extracellular signal-regulated kinase/Akt inhibition were involved in luteolin-induced apoptosis in Lewis lung carcinoma cells. Annals of the New York Academy of Sciences: 2007; 1095 598 611
24. Lee H. J., Wang C. J., Kuo H. C. et al. Induction apoptosis of luteolin in human hepatoma HepG2 cells involving mitochondria translocation of Bax/Bak and activation of JNK. Toxicology and Applied Pharmacology: 2005; 203 124 131
25. Choia A. Y., Choia J. H., Yoona H. et al. Luteolin induces apoptosis through endoplasmic reticulum stress and mitochondrial dysfunction in Neuro-2a mouse neuroblastoma cells. European Journal of Pharmacology: 2011; 668 115 126
26. Jacobson M. D., Weil M., Raff M. C. Programmed cell death in animal development. Cell: 1997; 88 347 354
27. Golstein P. Controlling cell death. Science: 1997; 275 1081 1082
28. King K. L., Cidlowsky J. A. Cell cycle and apoptosis: common pathways to life and death. J Cell Biochemistry: 1995; 58 175 180